Status:
RECRUITING
Evaluation of Improvements in Patient-reported Quality of Life
Lead Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Conditions:
Breast Cancer
Quality of Life
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning ...
Detailed Description
Local intervention trial which will evaluate the potential of using real-world patient measurements collected by the REBECCA system for improving the patient-reported quality-of-life, through just-in-...
Eligibility Criteria
Inclusion
- Before patient registration, written informed consent must be given according to national and local regulations.
- Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.
- Be between 18 and 75 years of age.
- Have increased life expectancy beyond the initial 3 months post-treatment initiation.
- Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
- Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
Exclusion
- Patients that are not willing to sign an informed consent form
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06002022
Start Date
January 1 2024
End Date
December 31 2025
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universitario de Valencia
Valencia, Spain, 46010